Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial

Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial

Background Cardiovascular disease remains an important comorbidity in patients with rheumatoid arthritis (RA), but traditional models do not accurately predict cardiovascular risk in patients with RA. The addition of biomarkers could improve prediction. Methods and Results The TARGET (Treatments Aga...

Full description

Bibliographic Details
Main Authors: Daniel H. Solomon, Olga Demler, Pamela M. Rist, Leah Santacroce, Ahmed Tawakol, Jon T. Giles, Katherine P. Liao, Joan M. Bathon
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
biomarkers
cardiovascular disease
rheumatoid arthritis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032095

Similar Items

Similar Items